denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Monoclonal Gammopathies: When the Clone Is More Than a Positive Laboratory Finding
Session: Monoclonal Gammopathies: When the Clone Is More Than a Positive Laboratory Finding
Saturday, December 7, 2024, 4:00 PM-5:15 PM
Disclosures: Liedtke: Biomea: Research Funding; BMS: Membership on an entity's Board of Directors or advisory committees, Research Funding; Caelum/Alexion: Research Funding; Gilead: Research Funding; Janssen: Membership on an entity's Board of Directors or advisory committees, Research Funding; Kite: Membership on an entity's Board of Directors or advisory committees; Nexcella: Membership on an entity's Board of Directors or advisory committees; Seagen: Research Funding; Abbvie: Membership on an entity's Board of Directors or advisory committees, Research Funding; Allogene: Research Funding.
See more of: Monoclonal Gammopathies: When the Clone Is More Than a Positive Laboratory Finding
See more of: Education Program
See more of: Education Program
Previous Presentation
|
Next Presentation >>